
Alnylam in US$2.8bn biobucks deal with Roche
The deal, which could fetch Alnylam Pharmaceuticals Inc up to US$2.8bn if all milestones are met and marketing approval is granted, clearly marks Big...

More marine plastics than expected
Researchers led by Mikael Kaandorp from German FZ Jülich and colleagues from Utrecht University report that plastic pieces larger than 2.5 cm, which...

BenevolentAI Ltd inks US$594m partnership with Merck KGaA
Under the licence agreement, BenevolentAI will identify and develop new compounds against three targets provided by Merck through hit identification...

BioLamina AB bags €19m funding for expansion
The tenth investement from Lauxera Capital Partners through its Lauxera Growth I fund will be usesd by the Swedish company to expand the development...

EG 427 expands Series A closing to €18m
EF 147, which got the additional €5m from undisclosed existing investors and new family office investors, is going to finance preclinical work upon...

Austrian Kern Tec raises €12m in Series A financing
Food tech specialist Kern Tec GmbH (Vienna) will use €12m from a €12m Series financing to scale up manufacturing of dairy products from upcycled...

Radiotherapy R&D partnership
French-US company Orano Med is developing Lead-212 (212Pb) Targeted Alpha Therapy, which combines the ability of biological molecules such as...